Literature DB >> 16873002

Inflammatory bowel disease--environmental modification and genetic determinants.

Subra Kugathasan1, Devendra Amre.   

Abstract

Inflammatory bowel disease (IBD) is a complex disease, controlled by multiple risk factors that evolve and interact together. In a genetically susceptible host, there are multiple processing steps controlled by the host and the environment, from environmental exposure to the clinical and biological expression of IBD-related phenotypes. This article discusses the recent genetic discoveries, along with the proposed environmental risk factors that have been implicated in IBD. Technical advances of the HapMap project and the promise of whole genome association scans have given hopes for clarifying gene-environmental interactions in IBD that ultimately lead to a clearer understanding of the pathogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16873002     DOI: 10.1016/j.pcl.2006.05.009

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  11 in total

Review 1.  The role of diet in the aetiopathogenesis of inflammatory bowel disease.

Authors:  Hamed Khalili; Simon S M Chan; Paul Lochhead; Ashwin N Ananthakrishnan; Andrew R Hart; Andrew T Chan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-09       Impact factor: 46.802

2.  Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases.

Authors:  R Alan Harris; Dorottya Nagy-Szakal; Natalia Pedersen; Antone Opekun; Jiri Bronsky; Pia Munkholm; Cathrine Jespersgaard; PaalSkytt Andersen; Bela Melegh; George Ferry; Tine Jess; Richard Kellermayer
Journal:  Inflamm Bowel Dis       Date:  2012-03-29       Impact factor: 5.325

3.  Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.

Authors:  Magali Fasseu; Xavier Tréton; Cécile Guichard; Eric Pedruzzi; Dominique Cazals-Hatem; Christophe Richard; Thomas Aparicio; Fanny Daniel; Jean-Claude Soulé; Richard Moreau; Yoram Bouhnik; Marc Laburthe; André Groyer; Eric Ogier-Denis
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

Review 4.  MicroRNA in inflammatory bowel disease: Translational research and clinical implication.

Authors:  Kurt Fisher; Jingmei Lin
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

5.  Early-Life Exposure to Antibiotics and Risk for Crohn's Disease: A Nationwide Danish Birth Cohort Study.

Authors:  Anders Mark-Christensen; Aksel Lange; Rune Erichsen; Trine Frøslev; Buket Öztürk Esen; Henrik Toft Sørensen; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2022-03-02       Impact factor: 5.325

Review 6.  Inflammatory bowel disease in children: current trends.

Authors:  Gargi Shikhare; Subra Kugathasan
Journal:  J Gastroenterol       Date:  2010-04-23       Impact factor: 6.772

7.  Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States.

Authors:  Hoda M Malaty; Jason K Hou; Selvi Thirumurthi
Journal:  Clin Exp Gastroenterol       Date:  2010-12-06

8.  Herb-Partitioned Moxibustion and the miRNAs Related to Crohn's Disease: A Study Based on Rat Models.

Authors:  Kai Wei; Dan Zhang; Jue Hong; Cuihong Zhang; Xiaoming Feng; Yan Huang; Jie Liu; Lingxiang Wu; Huangan Wu; Xiaopeng Ma
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-25       Impact factor: 2.629

9.  Feasibility of salivary DNA collection in a population-based case-control study: a pilot study of pediatric Crohn's disease.

Authors:  Michael D Kappelman; Aksel Lange; Rachel L Randell; Patricia V Basta; Robert S Sandler; Kristina Laugesen; Anna Byrjalsen; Tina Christensen; Trine Frøslev; Rune Erichsen
Journal:  Clin Epidemiol       Date:  2018-02-28       Impact factor: 4.790

10.  Elevated miRNA Inversely Correlates with E-cadherin Gene Expression in Tissue Biopsies from Crohn Disease Patients in contrast to Ulcerative Colitis Patients.

Authors:  Małgorzata Guz; Tomasz Dworzański; Witold Jeleniewicz; Marek Cybulski; Joanna Kozicka; Andrzej Stepulak; Krzysztof Celiński
Journal:  Biomed Res Int       Date:  2020-07-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.